Clinical Trial Update: Management of Imatinib-associated Severe Skin Rash in Patients With Gastrointestinal Stromal Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial update addressing management of imatinib-associated severe skin rash in patients with gastrointestinal stromal tumor (GIST).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Gastrointestinal Stromal Tumor(GIST) | Phase 2 | Status: COMPLETED